DK0436307T3 - Substituerede oxophthalazinyleddikesyrer og analoger deraf - Google Patents

Substituerede oxophthalazinyleddikesyrer og analoger deraf

Info

Publication number
DK0436307T3
DK0436307T3 DK90313128.2T DK90313128T DK0436307T3 DK 0436307 T3 DK0436307 T3 DK 0436307T3 DK 90313128 T DK90313128 T DK 90313128T DK 0436307 T3 DK0436307 T3 DK 0436307T3
Authority
DK
Denmark
Prior art keywords
substituted
acetic acids
analogs
oxophthalazinyl acetic
oxophthalazinyl
Prior art date
Application number
DK90313128.2T
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0436307T3 publication Critical patent/DK0436307T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90313128.2T 1989-12-15 1990-12-04 Substituerede oxophthalazinyleddikesyrer og analoger deraf DK0436307T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005637 WO1991009019A1 (en) 1989-12-15 1989-12-15 Substituted oxophthalazinyl acetic acids and analogs thereof

Publications (1)

Publication Number Publication Date
DK0436307T3 true DK0436307T3 (da) 1995-05-08

Family

ID=22215419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90313128.2T DK0436307T3 (da) 1989-12-15 1990-12-04 Substituerede oxophthalazinyleddikesyrer og analoger deraf

Country Status (13)

Country Link
US (1) US5304557A (da)
EP (1) EP0436307B1 (da)
JP (1) JPH0660163B2 (da)
AT (1) ATE118768T1 (da)
CA (1) CA2032231C (da)
DE (1) DE69017174T2 (da)
DK (1) DK0436307T3 (da)
ES (1) ES2068350T3 (da)
FI (1) FI922308A7 (da)
GR (1) GR3015852T3 (da)
IE (1) IE65294B1 (da)
PT (1) PT96175B (da)
WO (1) WO1991009019A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
CA2383983C (en) * 1998-03-31 2009-09-29 The Institutes For Pharmaceutical Discovery, Llc Substituted indolealkanoic acids
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
MXPA05001011A (es) * 2002-07-26 2005-06-08 Inst For Pharm Discovery Inc Derivado de acidos indolalcanoicos substituidos y formulaciones que lo contienen para uso en tratamiento de complicaciones diabeticas.
KR100843352B1 (ko) * 2007-01-30 2008-07-03 한국과학기술연구원 세로토닌 수용체 5-HT2a 또는 5-HT2c의 길항제로활성을 갖는 1,2-다이하이드로-1-옥소프탈라지닐 피페라진화합물 및 이의 제조방법
EP3192796B1 (en) * 2010-07-16 2019-09-04 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) * 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
DK3352754T3 (da) 2016-06-21 2020-12-07 Univ Columbia Aldosereduktaseinhibitorer og fremgangsmåder til anvendelse deraf
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
JP7457033B2 (ja) * 2019-02-28 2024-03-27 石薬集団中奇制薬技術(石家庄)有限公司 アルドース還元酵素阻害剤の塩、及びその製造方法と使用
CN113840825A (zh) 2019-04-01 2021-12-24 应用治疗公司 醛糖还原酶抑制剂
WO2020227430A1 (en) 2019-05-07 2020-11-12 University Of Miami Treatment and detection of inherited neuropathies and associated disorders
US20230202989A1 (en) * 2020-05-28 2023-06-29 Janssen Pharmaceutica Nv Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3003249A1 (de) * 1980-01-30 1981-08-06 Henkel KGaA, 4000 Düsseldorf Mittel zum nachbehandeln gewaschener waesche in einem waeschetrockner
US4904478A (en) * 1983-08-11 1990-02-27 Mission Pharmacal Company Slow-release sodium fluoride tablet and method for treatment of osteoporosis
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate

Also Published As

Publication number Publication date
ES2068350T3 (es) 1995-04-16
EP0436307B1 (en) 1995-02-22
DE69017174D1 (de) 1995-03-30
DE69017174T2 (de) 1995-06-14
FI922308L (fi) 1992-05-21
CA2032231A1 (en) 1991-06-16
GR3015852T3 (en) 1995-07-31
PT96175A (pt) 1991-09-30
US5304557A (en) 1994-04-19
IE904508A1 (en) 1991-06-19
JPH0660163B2 (ja) 1994-08-10
CA2032231C (en) 1995-08-22
ATE118768T1 (de) 1995-03-15
FI922308A0 (fi) 1992-05-21
JPH03258766A (ja) 1991-11-19
FI922308A7 (fi) 1992-05-21
IE65294B1 (en) 1995-10-18
PT96175B (pt) 1998-04-30
WO1991009019A1 (en) 1991-06-27
EP0436307A1 (en) 1991-07-10

Similar Documents

Publication Publication Date Title
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
DK0776324T3 (da) Endothelin-antagonister
DK0436307T3 (da) Substituerede oxophthalazinyleddikesyrer og analoger deraf
FI906045A0 (fi) Kvaevehaltiga spirocykliska foereningar.
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
MX9203032A (es) Una solucion farmaceutica.
DK724088A (da) Purinyl- pyrimidinylcyclobutaner
AU4194693A (en) New piperidine derivatives of benzimidazole
DE68918681D1 (de) Glycosidasehemmer.
SE8600017D0 (sv) New compound
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
DE69028610D1 (de) Chirale 1,5-diiodo-2-methoxy oder benzyloxy Zwischenprodukte
DK1031556T3 (da) 2-phenoxyanilinderivater
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ATE155127T1 (de) Benzamid-derivate
ATE114309T1 (de) N-azabicyclo(3.3.0>octanamide von aromatischen säuren.
DK0408053T3 (da) Monocycliske terpenderivater
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
MX9205408A (es) Metodo para tratar hipertension.
ES2033859T3 (es) Acidos y esteres 2-amino-3-aroil-gamma-oxobencenbutanoicos.
DE69314573D1 (de) 2-Thiazolylpyrroleakrylate mit fungizider Wirkung
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.